Acasti Pharma Inc (ACST) is near the top in its industry group according to InvestorsObserver. ACST gets an overall rating of 61. That means it scores higher than 61 percent of stocks. Acasti Pharma Inc gets a 83 rank in the Biotechnology industry. Biotechnology is number 91 out of 148 industries.
Click Here to get the full Stock Score Report on Acasti Pharma Inc (ACST) Stock.
What do These Ratings Mean?
Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector.
Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.
What's Happening With Acasti Pharma Inc Stock Today?
Acasti Pharma Inc (ACST) stock is unchanged 0.26% while the S&P 500 is higher by 0.95% as of 11:18 AM on Friday, Dec 6. ACST is unchanged $0.00 from the previous closing price of $1.90 on volume of 603,443 shares. Over the past year the S&P 500 is higher by 16.73% while ACST is higher by 180.88%. ACST lost -$1.25 per share the over the last 12 months.
